PTSD: A Patient’s Perspective
According to the National Institutes of Health, approximately 7.7 million American adults age 18 and older suffer symptoms of post-traumatic stress disorder (PTSD). Thankfully, emerging treatments are providing relief and recovery, even in the most severe cases.
PTSD: A Physician’s Perspective
Dr. Alina Suris has developed a cellular therapy to treat PTSD for which she has won a George Winokur Research Award.
Leading Innovation and Supply Chain Safety
As president and CEO of TraceLink,Inc., Shabbir Dahod leads a visionary team that helps companies meet the complex requirements of the Drug Supply Chain Security Act.
The Growth of the Plasma Market
In this annual plasma-themed issue of BioSupply Trends Quarterly, we take a critical look at the current plasma market, especially issues of supply and demand.
Stroke Prevention: A Patient’s Perspective
At age 41, Eric Jordan suffered a massive ischemic stroke and lost his ability to speak.
Stroke Prevention: A Physician’s Perspective
Dr. Philip Meyers treats vascular disorders of the brain and spinal cord using minimally invasive, image-guided techniques.
Healthcare Solutions: Peering Into the Future
As we peer into the not-too-distant future, is it possible that some of the treatments that seem so innovative today will also be looked back upon as unsophisticated?
Celebrating Five Years of BioSupply Reporting
From a bi-weekly newsletter to an award-winning quarterly magazine, BioSupply Trends Quarterly has grown to be a timely, trustworthy source for biopharmaceutical news.
Acquired Hemophilia: A Physician’s Perspective
Dr. Craig Kessler has been a specialist in acquired hemophilia since the late 1980s.
Helping Healthcare Care for More than 25 Years
As CEO of FFF Enterprises, Inc., Patrick Schmidt takes pride in his company’s success in helping to secure the specialty biopharmaceuticals marketplace over the past 26 years.